CVT - CVENT, INC.

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Moody's2 months ago

    Cvent, Inc. -- Moody's affirms Cvent CFR and Sr Sec at B3; outlook revised to stable from positive

    Moody's Investors Service ("Moody's") affirmed Cvent Inc.'s ("Cvent") Corporate Family rating ("CFR") at B3, Probability of Default rating ("PDR") at B3-PD and senior secured first lien revolver and term loan at B3. The rating outlook was revised to stable from positive. On Tuesday, Cvent announced it had acquired Social Tables, Inc. ("Social Tables") in a debt-financed transaction funded in part by a $53 million increase in its senior secured 1st lien term loan, bringing the total outstanding amount to approximately $750 million.

  • Reuters8 months ago

    Deals of the day-Mergers and acquisitions

    The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday: ** Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. ** Pebblebrook Hotel Trust has sweetened its $3 billion-plus offer to buy U.S. peer LaSalle Hotel Properties after the owner of high-end locations including 'W' Los Angeles saw an initial bid rebuffed last month.

  • We're sorry this is all we were able to find about this topic.